An Updated Report on the Prevalence of Prior Cancer Among Persons Newly Diagnosed With Cancer in the Surveillance, Epidemiology, and End Results Program

Caitlin C Murphy; Guillermo A Tortolero; David E Gerber; Sandi L Pruitt

doi:10.1001/jamaoncol.2023.1723

An Updated Report on the Prevalence of Prior Cancer Among Persons Newly Diagnosed With Cancer in the Surveillance, Epidemiology, and End Results Program

JAMA Oncol. 2023 Aug 1;9(8):1147-1150. doi: 10.1001/jamaoncol.2023.1723.

Authors

Caitlin C Murphy¹, Guillermo A Tortolero¹, David E Gerber^{2

3

4}, Sandi L Pruitt^{3

4}

Affiliations

¹ University of Texas Health Science Center at Houston (UTHealth Houston) School of Public Health.
² Division of Hematology Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas.
³ Harold C. Simmons Comprehensive Cancer Center, Dallas, Texas.
⁴ Peter O'Donnell Jr School of Public Health, University of Texas Southwestern Medical Center, Dallas.

No abstract available

Plain language summary

This cohort study uses population-based data from the National Cancer Institute Surveillance, Epidemiology, and End Results program of cancer registries to estimate prevalence of prior cancer among adults diagnosed with an incident cancer in 2019.

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Incidence
Neoplasms* / diagnosis
Neoplasms* / epidemiology
Prevalence
Registries
SEER Program
United States / epidemiology

Grants and funding

R01 CA229834/CA/NCI NIH HHS/United States